1. 1. Crop F, Pasquier D, Baczkiewic A, et al. (2016) Surface imaging, laser positioning or volumetric imaging for breast cancer with nodal involvement treated by helical TomoTherapy. J Appl Clin Med Phys, 17(5): 200-11. [DOI:10.1120/jacmp.v17i5.6041]

2. Lauche O and Kirova YM (2014) Helical tomotherapy in breast cancer treatment. Breast Cancer Manag, 3(5): 441-9. [DOI:10.2217/bmt.14.34]

3. Parsai EI, Shvydka D, Pearson D, et al. (2008) Surface and build-up region dose analysis for clinical radiotherapy photon beams. Appl Radiat Isot, 66(10): 1438-42. [DOI:10.1016/j.apradiso.2008.02.089]

4. Akino Y, Das IJ, Bartlett GK, et al. (2013) Evaluation of superficial dosimetry between treatment planning system and measurement for several breast cancer treatment techniques. Med Phys, 40(1): 011714. [DOI:10.1118/1.4770285]

5. Panettieri V, Barsoum P, Westermark M, et al. (2009) AAA and PBC calculation accuracy in the surface build-up region in tangential beam treatments. Phantom and breast case study with the Monte Carlo code PENELOPE. Radiother Oncol, 93(1): 94-101. [DOI:10.1016/j.radonc.2009.05.010]

6. Chen M-F, Chen W-C, Lai C-H, et al. (2010) Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer, 10(1): 1-9. [DOI:10.1186/1471-2407-10-508]

7. Xie Y, Wang Q, Hu T, et al. (2021) Risk Factors Related to Acute Radiation Dermatitis in Breast Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis. Front Oncol, 29(11): 738851. [DOI:10.3389/fonc.2021.738851]

8. Mori M, Cattaneo G, Dell'Oca I, et al. (2019) Skin DVHs predict cutaneous toxicity in Head and Neck Cancer patients treated with Tomotherapy. Phys Med, 59: 133-41. [DOI:10.1016/j.ejmp.2019.02.015]

9. Farhood B, Toossi MTB, Soleymanifard S, et al. (2017) Assessment of the accuracy of dose calculation in the build-up region of the tangential field of the breast for a radiotherapy treatment planning system. Contemp Oncol (Pozn), 21(3): 232-9. [DOI:10.5114/wo.2017.70114]

10. Capelle L, Warkentin H, MacKenzie M, et al. (2012) Skin-sparing Helical Tomotherapy vs 3D-conformal radiotherapy for adjuvant breast radiotherapy: in vivo skin dosimetry study. Int J Radiat Oncol Biol Phys, 83(5): e583-e90. [DOI:10.1016/j.ijrobp.2012.01.086]

11. Zibold F, Sterzing F, Sroka-Perez G, et al. (2009) Surface dose in the treatment of breast cancer with helical tomotherapy. Strahlenther Onkol, 185(9): 574-81. [DOI:10.1007/s00066-009-1979-7]

12. Ramsey CR, Seibert RM, Robison B, et al. (2007) Helical tomotherapy superficial dose measurements. Med Phys, 34(8): 3286-93. [DOI:10.1118/1.2757000]

13. Kim S-Y, You S-H, Song T-S, et al. (2009) Superficial Dosimetry for Helical Tomotherapy. Radiat Oncol J, 27(2): 103-10. [DOI:10.3857/jkstro.2009.27.2.103]

14. Kowalik A, Konstanty E, Piotrowski T, et al. (2019) Calculation and measurement of doses in the surface layers of a phantom when using tomotherapy. Rep Pract Oncol Radiother, 24(2): 251-62. [DOI:10.1016/j.rpor.2018.11.006]

15. Avanzo M, Drigo A, Kaiser SR, et al. (2013) Dose to the skin in helical tomotherapy: results of in vivo measurements with radiochromic films. Phys Med, 29(3): 304-11. [DOI:10.1016/j.ejmp.2012.04.004]

16. Kinhikar RA, Murthy V, Goel V, et al. (2009) Skin dose measurements using MOSFET and TLD for head and neck patients treated with tomotherapy. Appl Radiat Isot, 67(9): 1683-5. [DOI:10.1016/j.apradiso.2009.03.008]

17. Snir JA, Mosalaei H, Jordan K, et al. (2011) Surface dose measurement for helical tomotherapy. Med Phys, 38(6Part1): 3104-7. [DOI:10.1118/1.3592021]

18. Hardcastle N, Soisson E, Metcalfe P, et al. (2008) Dosimetric verification of helical tomotherapy for total scalp irradiation. Med Phys, 35(11): 5061-8. [DOI:10.1118/1.2996288]

19. Goddu SM, Yaddanapudi S, Pechenaya OL, et al. (2009) Dosimetric consequences of uncorrected setup errors in helical Tomotherapy treatments of breast-cancer patients. Radiother Oncol, 93(1): 64-70. [DOI:10.1016/j.radonc.2009.07.013]

20. Cherpak A, Studinski RC, Cygler JE (2008) MOSFET detectors in quality assurance of tomotherapy treatments. Radiother Oncol, 86(2): 242-50. [DOI:10.1016/j.radonc.2007.10.025]

21. Zani M, Talamonti C, Bucciolini M, et al. (2016) In phantom assessment of superficial doses under TomoTherapy irradiation. Phys Med, 32(10): 1263-70. [DOI:10.1016/j.ejmp.2016.09.017]

22. Aydarous A (2014) Measurement and comparison of skin dose distribution in water phantom exposed to 6 MV photon beam. J Appl Sci, 14(17): 1952-8. [DOI:10.3923/jas.2014.1952.1958]

23. Reynolds TA and Higgins P (2015) Surface dose measurements with commonly used detectors: a consistent thickness correction method. J Appl Clin Med Phys, 16(5): 358-66. [DOI:10.1120/jacmp.v16i5.5572]

24. Toossi MTB, Mohamadian N, Mohammadi M, et al. (2020) Assessment of skin dose in breast cancer radiotherapy: on-phantom measurement and Monte Carlo simulation. Rep Pract Oncol Radiother, 25(3): 456-61. [DOI:10.1016/j.rpor.2020.03.008]

25. Srivastava RP and De Wagter C (2019) Clinical experience using Delta 4 phantom for pretreatment patient-specific quality assurance in modern radiotherapy. J Radiother Pract, 18(2): 210-4. [DOI:10.1017/S1460396918000572]

26. Li H, Dong L, Zhang L, et al. (2011) Toward a better understanding of the gamma index: Investigation of parameters with a surface‐based distance method a. Med Phys, 38(12): 6730-41. [DOI:10.1118/1.3659707]

27. Saadatmand P, Amouheidari A, Shanei A, et al. (2020) Dose perturbation due to dental amalgam in the head and neck radiotherapy: a phantom study. Med Dosim, 45(2): 128-33. [DOI:10.1016/j.meddos.2019.08.002]

28. Saadatmand P, Shanei A, Amouheidari A, et al. (2019) Evaluation of the effects of dental filling material artifacts on IMRT treatment planning in patient with nasopharyngeal cancer. Int J Radiat Res, 17(3): 477-83.

29. McDermott PN (2020) Surface dose and acute skin reactions in external beam breast radiotherapy. Med Dosim, 45(2): 153-8. [DOI:10.1016/j.meddos.2019.09.001]

30. Clarke R, Fry F, Stather J, et al. (1993) 1990 recommendations of the International Commission on Radiological Protection. Documents of the NRPB, 4(1): 1-5.

31. Tournel K, Verellen D, Duchateau M, et al. (2007) An assessment of the use of skin flashes in helical tomotherapy using phantom and in-vivo dosimetry. Radiother Oncol, 84(1): 34-9. [DOI:10.1016/j.radonc.2007.06.003]

32. Sterpin E, Salvat F, Olivera G, et al. (2009) Monte Carlo evaluation of the convolution/superposition algorithm of Hi‐Art™ tomotherapy in heterogeneous phantoms and clinical cases. Med Phys, 36(5): 1566-75. [DOI:10.1118/1.3112364]

33. Javedan K, Zhang G, Mueller R, et al. (2009) Skin dose study of chest wall treatment with tomotherapy. Jpn J Radiol, 27: 355-62. [DOI:10.1007/s11604-009-0357-9]

34. Higgins PD, Han E, Yuan J, et al. (2007) Evaluation of surface and superficial dose for head and neck treatments using conventional or intensity-modulated techniques. Phys Med Biol, 52(4): 1135. [DOI:10.1088/0031-9155/52/4/018]

35. Qi ZY, Deng XW, Huang SM, et al. (2009) In vivo verification of superficial dose for head and neck treatments using intensity‐modulated techniques. Med Phys, 36(1): 59-70. [DOI:10.1118/1.3030951]

36. Wang L, Cmelak AJ, Ding GX (2018) A simple technique to improve calculated skin dose accuracy in a commercial treatment planning system. J Appl Clin Med Phys, 19(2): 191-7. [DOI:10.1002/acm2.12275]

37. Hauri P, Verlaan S, Graydon S, et al. (2014) Clinical evaluation of an anatomy‐based patient specific quality assurance system. J Appl Clin Med Phys, 15(2): 181-90. [DOI:10.1120/jacmp.v15i2.4647]

38. Abedi Firouzjah R, Nickfarjam A, Bakhshandeh M, et al. (2019) The use of EBT3 film and Delta4 for the dosimetric verification of EclipseTM treatment planning system in a heterogeneous chest phantom: an IMRT technique. Int J Radiat Res, 17(2): 355-61.

39. Atiq M, Atiq A, Iqbal K, et al. (2017) Interpretation of gamma index for quality assurance of simultaneously integrated boost (SIB) IMRT plans for head and neck carcinoma. Polish J Med Phys Eng, 23(4): 93-7. [DOI:10.1515/pjmpe-2017-0016]

40. Grégoire V and Mackie T (2011) State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer Radiother, 15(6-7): 555-9. [DOI:10.1016/j.canrad.2011.04.003]